Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 168,597 | 151,620 | 118,180 | 83,740 | 65,620 |
| Gross Profit | 168,597 | 151,620 | 118,180 | 83,740 | 65,620 |
| Operating Expenses | 59,916 | 104,340 | 105,840 | 103,900 | 112,250 |
| Operating Income | 108,680 | 47,280 | 12,340 | -20,160 | -46,630 |
| Interest Expense | 4,398 | 4,590 | 0 | 0 | 0 |
| Other Income | 8,438 | 10,320 | -700 | 450 | 7,400 |
| Pre-tax Income | 112,720 | 53,010 | 11,640 | -19,710 | -39,230 |
| Income Tax | -891 | -700 | -840 | -450 | 1,100 |
| Net Income Continuous | 113,611 | 53,720 | 13,032 | -19,258 | -38,165 |
| Net Income Discontinuous | N/A | 0 | 7,510 | -64,910 | -71,170 |
| Net Income | $113,611 | $53,720 | $20,010 | $-84,170 | $-111,520 |
| EPS Basic Total Ops | 1.94 | 0.95 | 0.41 | -1.83 | -2.35 |
| EPS Basic Continuous Ops | 1.94 | 0.95 | 0.26 | -0.42 | -0.85 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.15 | -1.41 | -1.58 |
| EPS Diluted Total Ops | 1.87 | 0.94 | 0.40 | -1.83 | -2.35 |
| EPS Diluted Continuous Ops | 1.87 | 0.94 | 0.25 | -0.42 | -0.85 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.14 | -1.41 | -1.58 |
| EBITDA(a) | $113,416 | $47,280 | $12,340 | $-20,160 | $-46,630 |